Pfizer Inc. v. Teva Pharmaceuticals USA, Inc.
Pfizer Inc. |
Teva Pharmaceuticals USA, Inc. |
1:2018cv01940 |
December 7, 2018 |
US District Court for the District of Delaware |
Leonard P Stark |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 |
None |
Docket Report
This docket was last retrieved on January 31, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Pro Hac Vice Attorney J.C. Rozendaal, Chandrika Vira, and Lauren Watt for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
SO ORDERED, re #7 MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal, Chandrika Vira, and Lauren Watt filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Leonard P. Stark on 1/30/19. (ntl) |
Filing 7 MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal, Chandrika Vira, and Lauren Watt - filed by Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Certification of J.C. Rozendaal, #2 Certification of Chandrika Vira, #3 Certification of Lauren Watt)(Brauerman, Stephen) |
Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
Filing 6 WAIVER OF SERVICE returned executed by Pfizer Inc.: For Teva Pharmaceuticals USA, Inc. waiver sent on 12/7/2018, answer due 2/5/2019. (Blumenfeld, Jack) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Pfizer Inc. (ceg) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,937,181 B2. (ceg) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/31/2018. Date of Expiration of Patent: 3/14/2034. (ceg) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
Filing 1 COMPLAINT FOR PATENT INFRIGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2519566.) - filed by Pfizer Inc. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(ceg) |
Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA, Inc. on 12/7/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.